Merckhas confirmed that ERVEBO has now been registered by National Health Authorities in the following countries in Africa – DRC, Burundi, Ghana, and Zambia.
ERVEBO was granted a conditional marketing authorization by the European Commission on November 11, 2019 and approved by
Evidence Aid have been watching the progression of the Coronavirus. Because the outbreak is leading to a rapidly expanding and evolving literature, they have curated a page of entry points to this literature which you can see here: ...
Evidence Aid have been watching the progression of the Coronavirus. Because the outbreak is leading to a rapidly expanding and evolving literature, they have curated a page of entry points to this literature which you can see here: ...
The Public Health Agency of Canada is denying any connection between the National Microbiology Lab in Winnipeg, two scientists who were escorted out of the building last summer, and the coronavirus outbreak in China.
“What we have developed is like a living Velcro that removes and traps pathogens”
Nature-inspired wipes and masks which could capture and trap the Wuhan Coronavirus (2019-nCoV) are being developed by scientists at the Irish company Aquila Bioscience. This technology can be used
The M72/AS01E tuberculosis vaccine candidate demonstrated in a phase IIb trial the potential to reduce active pulmonary TB by half in adults with latent TB infection.
The Partnership for Research on Ebola Vaccination (PREVAC) has launched a project called PREVAC-UP with the aim of evaluating three Ebola vaccine regimens for five years after vaccination.
The study will assess several factors of these treaments
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, has announced that the Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR),
Emergex Vaccines Holding Limited (‘Emergex’), a biotechnology company developing set-point vaccines to prevent serious infectious diseases, has announced the successful completion of the first step in the development of a candidate vaccine for the Gram-negative intracellular
Soligenix, Inc. has announced that it has opened the study titled "A Phase 1C, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety of RiVax,
On Tuesday December 3rd a patient was admitted to a specialist unit at St Thomas' Hospital in central London after Public Health England confirmed a diagnosis of Monkeypox.
It is believed the individual contracted the virus whilst visting Nigeria, which has seen at least four
SIGA Technologies, Inc. today announced that the Canadian Department of National Defence (CDND) has issued an advanced contract award notice (ACAN), indicating that it intends to award a contract to fund regulatory filing with Health Canada for approval of oral TPOXX®.
Merck , known as MSD outside the United States and Canada, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola
GlaxoSmithKline plc has announced the divestment of travel vaccines Rabipur (tradename Rabavert in the US) for the prevention of rabies, and Encepur for the prevention of tick-borne encephalitis, to Bavarian Nordic.
The decision to divest these brands, acquired from Novartis in 2015 as
Porton Biopharma Ltd (PBL) has today announced that it has signed a modification to its contract (HHSN272201600045C) with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on Thursday allowed the marketing of the first rapid diagnostic test for the Ebola virus that has not been authorized via the agency’s Emergency Use Authorization (EUA) pathway.
The Sabin Vaccine Institute (Sabin) has announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services. Under the terms of this agreement,
SIGA Technologies, Inc. announced on October 3rd that it has reached concurrence with the US Food and Drug Administration (FDA) that no further clinical studies will be required for the IV formulation of TPOXX (tecovirimat), and SIGA anticipates filing the New Drug Application (NDA) for this
It was annonuced on September 24th that the Biomedical Advanced Research and Development Authority (BARDA) intends to provide $14 millio, as well as expertise support for the advanced development of an investigational Ebola treatment being pursued by Ridgeback Biotherapeutics of
The FDA has approved the Jynneos vaccine by Bavarian Nordic for the prevention of Smallpox and Monkeypox in adults 18 years of age and older determined to be at high risk for these infections.
Jynneos is a live vaccine produced from the strain Modified Vaccinia Ankara-Bavarian Nordic
BioFactura, Inc. announced on September 26th a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $67.4 million for the advanced development of its Smallpox Biodefense Therapeutic as a potential medical countermeasure (MCM) for the treatment
Researchers from The University of California, Davis, have recenctly publsihed their findings regarding the discovery of the sitxth ebolavirus, Bombali, in Angolan free-tailed bats roosting inside people’s houses in Guéckedou and Kissidougou, Guinea.
Speaking at the Shanghai Cooperation Organisation's (SCO) First Military Medicine Conference this week, India's Defence Minister Rajnath Singh referred to bioterrorism as a 'contagious plague', and called upon the Armed Forces Medical Services (AFMS) of the SCO countries to
The U.S. Department of Health and Human Services (HHS) announced this week that they will be purchasing a smallpox vaccine, called ACAM2000, to build and replenish vaccine stored in the ...
As part of the international response to the Ebola virus outbreak in the Democratic Republic of the Congo (DRC) and to meet domestic biodefense goals, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will support
Following an inspection in June, the CDC has issued a cease-and-desist order to the Fort Detrick biodefense lab. All research at the lab, run by the Army Medical Research Institute of Infectious Diseases (USAMRIID), is now on hold until further notice.
GeoVax Labs, Inc.has announced positive results (100% protection) from preclinical challenge studies of its Marburg virus vaccine candidate; Marburg virus a critical medical threat against which there is currently no available vaccine or treatment. This study data adds to that showing similar
New tools for programmable modulation of gene expression could yield enhanced resilience against influenza and ionizing radiation for service members and first responders.
Breakthroughs in the science of programmable gene expression inspired DARPA to ...
SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on the health security market, today announced that it has entered into an international promotion agreement with Meridian Medical Technologies, Inc. Under the agreement, Meridian will promote the sale of oral TPOXX for
Zhilong Yang, an assistant professor in the Division of Biology, is the principal investigator on a new, nearly $1.9 million grant from the National Institutes of Health. The five-year project will study how vaccinia virus — a member of the poxvirus family — produces its proteins. This award is
Valneva SE (“Valneva”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, and the Coalition for Epidemic Preparedness Innovations (CEPI) hereby announce a new partnering agreement.
BioFire Defense, LLC, an affiliate of bioMérieux and leader in pathogen detection systems for the U.S. Department of Defense, was awarded the 2019 James S. Cogswell Outstanding Industrial Achievement Award from the DoD’s Defense Security Service (DSS). This award was presented to the company’s
Arizona State University has announced that it has been selected by the U.S. Defense Advanced Research Projects Agency (DARPA) to build a field-deployable, point-of-care device that will determine in 30 minutes or less if a person has been exposed to weapons of mass destruction or
In response to the WHO declaring the Ebola outbreak in the DRC a Public Health Emergency of International Concern (PHEIC), the U.S. National Library of Medicine has made available to all the Ebola Outbreak: 2018-Present Health Information Guide.
DASA is inviting expressions of interest for a launch event on 1 October 2019 for our 'Don’t Blow It! Safely eliminating chemical and biological munitions on the battlefield' competition.
CEPI has awarded a contract worth up to US$12.5 million to a consortium led by Wageningen Bioveterinary Research to develop a human vaccine against Rift Valley fever.
Wageningen Bioveterinary Research (WBVR), part of Wageningen University & Research, and the Coalition for
SIGA Technologies announced today that they have been awarded a multi-year contract by the U.S. Department of Defense (DOD) to support the work necessary to gain a potential label expansion for TPOXX that would include its use for post-exposure prophylaxis (PEP) for Smallpox.
The U.S Government Accountability Office (GAO) has released a report identifying what it feels are key challenges in the nation's ability to detect and respond to biological events that transcend what a single agency can address.
On July 2nd the United States Agency for International Development (USAID) announced they would be giving $98 million to the Democratic Republic of Congo (DRC) to assist in the fight against the current Ebola outbreak.
"With this funding, USAID is providing lifesaving assistance,
The Russian Federation Security Council press secretary, Yevgeniy Anoshin, informed journalists that the secretary of the Russian Security Council, Nikolay Patrushev, and his counterpart from Uzbekistan, Viktor Makhmudov, signed a memorandum in Ufa on